These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 22269172)
1. Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells. Lim DY; Cho HJ; Kim J; Nho CW; Lee KW; Park JH BMC Gastroenterol; 2012 Jan; 12():9. PubMed ID: 22269172 [TBL] [Abstract][Full Text] [Related]
2. Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. Kim EJ; Kang IJ; Cho HJ; Kim WK; Ha YL; Park JH J Nutr; 2003 Aug; 133(8):2675-81. PubMed ID: 12888657 [TBL] [Abstract][Full Text] [Related]
3. Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. Kim IH; Nam TJ Oncol Rep; 2018 Mar; 39(3):1516-1522. PubMed ID: 29328495 [TBL] [Abstract][Full Text] [Related]
4. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein. Kim EJ; Shin HK; Park JH J Med Food; 2005; 8(4):431-8. PubMed ID: 16379552 [TBL] [Abstract][Full Text] [Related]
5. Luteolin inhibits proliferation induced by IGF-1 pathway dependent ERα in human breast cancer MCF-7 cells. Wang LM; Xie KP; Huo HN; Shang F; Zou W; Xie MJ Asian Pac J Cancer Prev; 2012; 13(4):1431-7. PubMed ID: 22799344 [TBL] [Abstract][Full Text] [Related]
6. trans-10,cis-12 conjugated linoleic acid inhibits insulin-like growth factor-I receptor signaling in TSU-Pr1 human bladder cancer cells. Jung JI; Cho HJ; Kim J; Kwon DY; Park JH J Med Food; 2010 Feb; 13(1):13-9. PubMed ID: 20136431 [TBL] [Abstract][Full Text] [Related]
7. Kaempferol Downregulates Insulin-like Growth Factor-I Receptor and ErbB3 Signaling in HT-29 Human Colon Cancer Cells. Lee HS; Cho HJ; Kwon GT; Park JH J Cancer Prev; 2014 Sep; 19(3):161-9. PubMed ID: 25337585 [TBL] [Abstract][Full Text] [Related]
8. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells. Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. Vanamala J; Reddivari L; Radhakrishnan S; Tarver C BMC Cancer; 2010 May; 10():238. PubMed ID: 20504360 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways. Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway. Kurihara S; Hakuno F; Takahashi S Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049 [TBL] [Abstract][Full Text] [Related]
12. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily. Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155 [TBL] [Abstract][Full Text] [Related]
13. Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation. Ganguly S; Basu B; Shome S; Jadhav T; Roy S; Majumdar J; Dasgupta PS; Basu S Am J Pathol; 2010 Dec; 177(6):2701-7. PubMed ID: 21075859 [TBL] [Abstract][Full Text] [Related]
14. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
15. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway. Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502 [TBL] [Abstract][Full Text] [Related]
16. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway. Doepfner KT; Spertini O; Arcaro A Leukemia; 2007 Sep; 21(9):1921-30. PubMed ID: 17581609 [TBL] [Abstract][Full Text] [Related]
17. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines. Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208 [TBL] [Abstract][Full Text] [Related]
18. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells. Furuhashi S; Sugita H; Takamori H; Horino K; Nakahara O; Okabe H; Miyake K; Tanaka H; Beppu T; Baba H Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280 [TBL] [Abstract][Full Text] [Related]
19. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo. Ji QS; Mulvihill MJ; Rosenfeld-Franklin M; Cooke A; Feng L; Mak G; O'Connor M; Yao Y; Pirritt C; Buck E; Eyzaguirre A; Arnold LD; Gibson NW; Pachter JA Mol Cancer Ther; 2007 Aug; 6(8):2158-67. PubMed ID: 17671083 [TBL] [Abstract][Full Text] [Related]
20. Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study. Shukla S; Gupta S Mol Carcinog; 2009 Mar; 48(3):243-252. PubMed ID: 18726972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]